Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule

Molecular Therapy

Volumn 9, Issue 5, 2004, Pages 712-720

  Pereboev, Alexander V ^a   Nagle, Jill M ^a   Shakhmatov, Mikhail A ^a   Triozzi, Pierre L ^a,b   Matthews, Qiana L ^a   Kawakami, Yusuke ^a   Curiel, David T ^a   Blackwell, Jerry L ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Adenovirus; Bispecific adapter; Dendritic cell; Gene transfer; Maturation; Targeting

Indexed keywords

ADENOVIRUS VECTOR; CD40 ANTIGEN; INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL LINE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE;

EID: 2442660248     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.02.006     Document Type: Article

References (37)

1. Ribas, A., Butterfield, L. H., Glaspy, J. A., and Economou, J. S. (2003). Current developments in cancer vaccines and cellular immunotherapy. J. Clin. Oncol. 21: 2415-2432.
2. Lopez, C. B., Moran, T. M., Schulman, J. L., and Fernandez-Sesma, A. (2002). Antiviral immunity and the role of dendritic cells. Int. Rev. Immunol. 21: 339-353.
3. Asiedu, C., et al. (2002). Rhesus monocyte-derived dendritic cells modified to overexpress TCF-beta1 exhibit potent veto activity. Transplantation 74: 629-637.
4. Copland, M. J., et al. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine 21: 883-890.
5. Jenne, L., Schuler, G., and Steinkasserer, A. (2001). Viral vectors for dendritic cell-based immunotherapy. Trends Immunol. 22: 102-107.
6. Tillman, B. W., et al. (1999). Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J. Immunol. 162: 6378-6383.
7. Okada, N., et al. (2003). Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors. Cancer Gene Ther. 10: 421-431.
8. Kita-Furuyama, M., et al. (2003). Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice. Clin. Exp. Immunol. 131: 234-240.
9. Rea, D., et al. (2001). Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J. Immunol. 166: 5236-5244.
10. Okada, N., et al. (2001). Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors. Biochem. Biophys. Res. Commun. 282: 173-179.
11. Hawiger, D., et al. (2001). Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
12. de Gruijl, T. D., et al. (2002). Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J. Immunol. 169: 5322-5331.
13. Tillman, B. W., Hayes, T. L., DeGruijl, T. D., Douglas, J. T., and Curiel, D. T. (2000). Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Cancer Res. 60: 5456-5463.
14. Brandao, J. G., et al. (2003). CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation. Vaccine 21: 2268-2272.
15. Pereboev, A. V., et al. (2002). Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells. Gene Ther. 9: 1189-1193.
16. Lortat-Jacob, H., Chouin, E., Cusack, S., and van Raaij, M. J. (2001). Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions. J. Biol. Chem. 276: 9009-9015.
17. Kashentseva, E. A., Seki, T., Curiel, D. T., and Dmitriev, I. P. (2002). Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain. Cancer Res. 62: 609-616.
18. Kim, J., et al. (2002). Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J. Virol. 76: 1892-1903.
19. van Kooten, C., and Banchereau, J. (2000). CD40-CD40 ligand. J. Leukocyte Biol. 67: 2-17.
20. Russell, W. C. (2000). Update on adenovirus and its vectors. J. Gen. Virol. 81: 2573-2604.
21. Korst, R. J., Mahtabifard, A., Yamada, R., and Crystal, R. G. (2000). Effect of adenovirus gene transfer vectors on the immunologic functions of mouse dendritic cells. Mol. Ther. 5: 307-315.
22. Miller, G., Lahrs, S., Pillarisetty, V. G., Shah, A. B., and DeMatteo, R. P. (2002). Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. Cancer Res. 62: 5260-5266.
23. Miller, G., Lahrs, S., Shah, A. B., and DeMatteo, R. P. (2003). Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus. Cancer Immunol. Immunother. 52: 347-358.
24. Molinier-Frenkel, V., et al. (2003). The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain. J. Biol. Chem. 278: 37175-37182.
25. Clement, A., et al. (2002). Converting nonhuman primate dendritic cells into potent antigen-specific cellular immunosuppressants by genetic modification. Immunol. Res. 26: 297-302.
26. Morris, A. E., et al. (1999). Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154). J. Biol. Chem. 274: 418-423.
27. Yang, X., et al. (2002). Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin. J. Virol. 76: 4634-4642.
28. Spriggs, M. K., et al. (1992). Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176: 1543-1550.
29. Wang, M., et al. (1995). Active immunotherapy of cancer with anonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154: 4685-4692.
30. Tomko, R. P., et al. (2000). Expression of the adenovirus receptor and its interaction with the fiber knob. Exp. Cell Res. 255: 47-55.
31. Dmitriev, I., Kashentseva, E., Rogers, B. E., Krasnykh, V., and Curiel, D. T. (2000). Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. J. Virol. 74: 6875-6884.
32. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., and Pease, L. R. (1989). Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68.
33. Armitage, R. J., et al. (1992). Molecular and biological characterization of a murine ligand for CD40. Nature 357: 80-82.
34. Krasnykh, V. N., Mikheeva, G. V., Douglas, J. T., and Curiel, D. T. (1996). Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70: 6839-6846.
35. Son, Y. I., et al. (2002). A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J. Immunol. Methods 262: 145-157.
36. Krasnykh, V., Belousova, N., Korokhov, N., Mikheeva, G., and Curiel, D. T. (2001). Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J. Virol. 75: 4176-4183.
37. Volpers, C., et al. (2003). Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin G-binding domain in the capsid. J. Virol. 77: 2093-2104.